cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Illumina Inc
68 own
47 watching
Current Price
$214.26
$-10.68
(-4.75%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
33,638.82M
52-Week High
52-Week High
371.16
52-Week Low
52-Week Low
173.45
Average Volume
Average Volume
1.14M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
68.9243
iconMarket Capitalization33,638.82M
icon52-Week High371.16
icon52-Week Low173.45
iconAverage Volume1.14M
iconDividend Yield--
iconP/E Ratio68.9243
What does the Illumina Inc do?
Illumina, Inc. provides sequencing and array-based solutions for genetic analysis. The company's sequencing by synthesis technology provides researchers with various applications and the ability to sequence mammalian genomes. It also offers arrays for a range of deoxyribonucleic acid and RNA analysis applications, including single nucleotide polymorphism genotyping, copy number variations analysis, gene expression analysis, and methylation analysis, as well as allow for the detection of known genetic markers on a single array. In addition, the company provides various library preparation and sequencing kits to simplify workflows and accelerate analysis; and genome sequencing, genotyping, and non-invasive prenatal testing services. It serves genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, agrigenomics, commercial molecular diagnostic laboratories, and consumer genomics companies. The company markets and distributes its products directly to customers in North America, Europe, Latin America, and the Asia-Pacific region, as well as through life-science distributors. It has collaboration agreements with IBM Watson Health to access genome data interpretation by integrating Watson for genomics into Illumina's BaseSpace Sequence Hub and tumor sequencing process; and NRGene to develop new molecular breeding tools for cattle to support global food production. The company also has a co-development agreement with Munich Leukemia Laboratory GmbH and IBM Watson Health to build a cognitive technology prototype to help researchers improve leukemia treatment. Illumina, Inc. was founded in 1998 and is headquartered in San Diego, California.
Read More
How much money does Illumina Inc make?
News & Events about Illumina Inc.
Accesswire
2days ago
NORTHAMPTON, MA / ACCESSWIRE / February 3, 2023 / IlluminaOriginally published on Illumina News CenterAccording to the World Health Organization, half the world's population does not have access to essential health services. At a time when advances in technology and medicine can make a real...
Accesswire
4days ago
NORTHAMPTON, MA / ACCESSWIRE / February 1, 2023 / Illumina has been included in the 2023 Bloomberg Gender-Equality Index for the fifth consecutive year. The distinguished index rates over 11,000 public companies and selects the top 500 committed to supporting gender equality in the workplace and...
PR Newswire
4days ago
Illumina Appoints Joydeep Goswami Chief Financial Officer Illumina Appoints Joydeep Goswami Chief Financial Officer PR Newswire SAN DIEGO, Feb. 1, 2023 SAN DIEGO, Feb. 1, 2023 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today...
Ticker Report
5days ago
Shares of Illumina, Inc. (NASDAQ:ILMN Get Rating) have received an average rating of Hold from the twenty-two research firms that are currently covering the stock, MarketBeat.com reports. Two investment analysts have rated the stock with a sell recommendation, six have issued a...
Accesswire
5days ago
NORTHAMPTON, MA / ACCESSWIRE / January 31, 2023 / IlluminaOriginally published on Illumina News CenterThe Festival of Genomics & Biodata 2023, held in London in January, is the largest event in the UK's genomics events calendar. More than 4000 delegates from health care, academia...
Frequently Asked Questions
Frequently Asked Questions
What is Illumina Inc share price today?
plus_minus_icon
Can Indians buy Illumina Inc shares?
plus_minus_icon
How can I buy Illumina Inc shares from India?
plus_minus_icon
Can Fractional shares of Illumina Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Illumina Inc stocks?
plus_minus_icon
What is today’s traded volume of Illumina Inc?
plus_minus_icon
What is today’s market capitalisation of Illumina Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Illumina Inc?
plus_minus_icon
What percentage is Illumina Inc down from its 52-Week High?
plus_minus_icon
What percentage is Illumina Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$214.26
$-10.68
(-4.75%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00